Josiah Ryman

881 total citations · 1 hit paper
11 papers, 623 citations indexed

About

Josiah Ryman is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Josiah Ryman has authored 11 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Molecular Biology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Josiah Ryman's work include Monoclonal and Polyclonal Antibodies Research (5 papers), Respiratory viral infections research (4 papers) and Pneumonia and Respiratory Infections (4 papers). Josiah Ryman is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), Respiratory viral infections research (4 papers) and Pneumonia and Respiratory Infections (4 papers). Josiah Ryman collaborates with scholars based in United States, Sweden and Germany. Josiah Ryman's co-authors include Bernd Meibohm, Jessica Weaver, Ka Lai Yee, Jeffrey R. Sachs, Natalie Banniettis, Tomás Martín‐Jiménez, Vibha Jawa, Mélanie J. Boileau, Anthony J. Hickey and Robert Kubiak and has published in prestigious journals such as The AAPS Journal, American Journal of Veterinary Research and Expert Review of Vaccines.

In The Last Decade

Josiah Ryman

9 papers receiving 607 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pharmacokinetics of Monoclonal Antibodies

2017 552 citations Josiah Ryman, Bernd Meibohm CPT Pharmacometrics & Systems Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Josiah Ryman United States	7	252	196	189	172	63	11	623
Nicolas Azzopardi France	15	205 0.8×	153 0.8×	159 0.8×	182 1.1×	47 0.7×	24	625
Judit Kocsis Hungary	15	206 0.8×	298 1.5×	102 0.5×	310 1.8×	41 0.7×	26	711
Qing Cheng China	9	86 0.3×	230 1.2×	94 0.5×	169 1.0×	42 0.7×	23	722
Anne‐Marie Quirke United Kingdom	10	100 0.4×	185 0.9×	185 1.0×	64 0.4×	49 0.8×	17	841
Susanne M. Scesney United States	14	189 0.8×	201 1.0×	405 2.1×	87 0.5×	58 0.9×	17	760
Zehra Kaymakcalan United States	8	201 0.8×	220 1.1×	205 1.1×	53 0.3×	59 0.9×	23	563
Vijay Joshua Sweden	14	234 0.9×	249 1.3×	259 1.4×	108 0.6×	113 1.8×	35	1.2k
Simone Kruithof Netherlands	14	342 1.4×	156 0.8×	393 2.1×	81 0.5×	96 1.5×	18	692
Karin A. van Schie Netherlands	12	317 1.3×	207 1.1×	336 1.8×	56 0.3×	36 0.6×	21	642
Philippe Poncelet France	12	113 0.4×	423 2.2×	279 1.5×	121 0.7×	41 0.7×	18	836

Countries citing papers authored by Josiah Ryman

Since Specialization

Citations

This map shows the geographic impact of Josiah Ryman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josiah Ryman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josiah Ryman more than expected).

Fields of papers citing papers by Josiah Ryman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josiah Ryman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josiah Ryman. The network helps show where Josiah Ryman may publish in the future.

Co-authorship network of co-authors of Josiah Ryman

This figure shows the co-authorship network connecting the top 25 collaborators of Josiah Ryman. A scholar is included among the top collaborators of Josiah Ryman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josiah Ryman. Josiah Ryman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Ryman, Josiah, et al.. (2025). Mechanism‐Based Modeling Approaches to Quantify the Effect of Immunogenicity on the Pharmacokinetics of Therapeutic Proteins in Drug Development. CPT Pharmacometrics & Systems Pharmacology. 14(9). 1431–1441.

2.

Gupta, Paridhi, Ashish Srivastava, Josiah Ryman, et al.. (2025). Short-Term Immunosuppression in Rats Induces Prolonged Immune Tolerance Towards a Human Monoclonal Antibody, Erenumab. The AAPS Journal. 27(4). 94–94.

3.

Ryman, Josiah, Jeffrey R. Sachs, Natalie Banniettis, et al.. (2024). Potential serotype-specific effectiveness against IPD of pneumococcal conjugate vaccines V114 and PCV20 in children given a 2+1 dosing regimen. Expert Review of Vaccines. 23(1). 467–473. 3 indexed citations

4.

Ryman, Josiah, Jeffrey R. Sachs, Ka Lai Yee, et al.. (2023). Predicted serotype-specific effectiveness of pneumococcal conjugate vaccines V114 and PCV20 against invasive pneumococcal disease in children. Expert Review of Vaccines. 23(1). 60–68. 8 indexed citations

5.

Ryman, Josiah, Jessica Weaver, Tianyan Hu, et al.. (2022). Predicting vaccine effectiveness against invasive pneumococcal disease in children using immunogenicity data. npj Vaccines. 7(1). 140–140. 6 indexed citations

6.

Ryman, Josiah, Jessica Weaver, Ka Lai Yee, & Jeffrey R. Sachs. (2022). Predicting effectiveness of the V114 vaccine against invasive pneumococcal disease in children. Expert Review of Vaccines. 21(10). 1515–1521. 10 indexed citations

7.

Hassanein, Mohamed, Michael A. Partridge, Vibha Jawa, et al.. (2022). Comparison of Titer and Signal to Noise (S/N) for Determination of Anti-drug Antibody Magnitude Using Clinical Data from an Industry Consortium. The AAPS Journal. 24(4). 81–81. 17 indexed citations

8.

Gonzalez‐Juarrero, Mercedes, Josiah Ryman, Gregory T. Robertson, et al.. (2021). Preclinical Evaluation of Inhalational Spectinamide-1599 Therapy against Tuberculosis. ACS Infectious Diseases. 7(10). 2850–2863. 11 indexed citations

9.

Ryman, Josiah & Bernd Meibohm. (2017). Pharmacokinetics of Monoclonal Antibodies. CPT Pharmacometrics & Systems Pharmacology. 6(9). 576–588. 552 indexed citations breakdown →

10.

Herskovitz, Jonathan, Josiah Ryman, Theingi M. Thway, et al.. (2017). Immune Suppression During Preclinical Drug Development Mitigates Immunogenicity-Mediated Impact on Therapeutic Exposure. The AAPS Journal. 19(2). 447–455. 8 indexed citations

11.

Ryman, Josiah, et al.. (2011). Pharmacokinetics of ponazuril after oral administration to healthy llamas (Lama glama). American Journal of Veterinary Research. 72(10). 1386–1389. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact